APP-BUTINACA is an analytical reference standard that is structurally similar to known synthetic cannabinoids. This product is intended for research and forensic applications.
- Product Name: APP-B
- IUPAC Name: (S)-N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-butyl-1H-indazole-3-carboxamide
- Other Names: APP-BINACA
- Molecular Formula: C21H24N4O2
- Appearance: Crystal and powder
- Application: Research purposes
- Availability: In Stock
- Packaging: Aluminum foil bag package done by expert
- Purity: 98.8%
- Origin: China
- Minimum order: 10 Grams
- Production Capacity: 100KG/WEEK
- Transportation: Delivery done by EMS, DHL, FEDEX, UPS and TNT
Clonazolam is a benzodiazepine that was developed as a central nervous system depressant in the 1970s and has recently emerged as a drug of abuse. It potently antagonizes convulsions induced by thiosemicarbazide and pentobarbital . This product is intended for forensic and research purposes.
JWH 018 is a synthetic cannabinoid (CB) that potently activates the central CB1 and peripheral CB2 receptors (Ki = 9.0 and 2.94 nM, respectively).This cannabimimetic compound has frequently been found in herbal blends. JWH 018 is distinguished by a terminal epoxide group on the alkyl chain. The biological and toxicological properties of this compound have not been characterized. This product is intended for forensic and research purposes.
Flubromazolam is an analog of the benzodiazepine flubromazepam. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research purposes only.
JWH 201 is a synthetic cannabinoid (CB) with relatively poor affinities for both CB1 (Ki = 1.1 μM) and CB2 (Ki = 0.44 μM) receptors. It is a para-
XLR11 is a synthetic cannabinoid (CB) featuring a tetramethylcyclopropyl group, which reportedly confers selectivity for the peripheral CB2 receptor over the central CB1 receptor. It also features an N-